The latest report on “Oral Cancer Treatment Market (Product Type – Squamous Cell Carcinoma, Verrucous Carcinoma, Minor Salivary Gland Carcinomas, and Lymphomas; Treatment – Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, and Other Treatments; Application – Hospitals and Clinics, Research Organization, and Academic Institutes): Global Industry Analysis, Trends, Size, Share and Forecasts to 2025.” The global oral cancer treatment market is projected to grow at a CAGR of 6.9% over the forecast period of 2019-2025.
Ask for Sample Copy of Research Report with Table of Content @ https://www.infiniumglobalresearch.com/reports/sample-request/14190
In 2019, Bristol-Myers Squibb Company announced the acquisition of Celgene Corporation, an American biotechnology company. The acquisition will create a premier innovative biopharma company. The leading players in the oral cancer treatment market are focusing on mergers, acquisitions, and new product launches to expand its market share. Major players in the oral cancer treatment market are Eli Lilly and Company, Merck & Co., Inc., F. Hoffmann-La-Roche Ltd., Teva Pharmaceutical Industries Ltd., Bristol-Myers Squibb Company, Novartis AG, Qilu Pharmaceutical Industries Ltd., Pfizer Inc., Sanofi, and Mylan N.V.
The increasing cases of oral cancer drive the growth of the oral cancer treatment market. Oral cancers are part of various cancers referred to as head and neck cancers. From all head and neck cancers, oral cancers comprise about 85%. As per Oral Cancer Foundation, around 9750 deaths happened in America due to oral cancer. The growing healthcare expenditure propels the growth of oral cancer treatment market. Factors such as rising taxes on tobacco and alcohol products, and oral cancer prevention programs stimulate the oral cancer treatment market. The increasing awareness about oral diseases drives the growth of oral cancer treatment market. On the flip side, side effects during the treatment and high cost of treatment restraint the growth of oral cancer treatment market. Moreover, research and development promote the advancement in the treatment of cancer that creates various opportunities for the growth of the oral cancer treatment market.
Based on geography, the global oral cancer treatment market is classified into North America, Europe, Asia-Pacific, and the Rest of the World. North America is anticipated to hold a premium share in the global oral cancer treatment market. North America has a well-established healthcare industry that drives the growth of the North America oral cancer treatment market. Also, the prevalence of oral cancer in America fuels the growth of the global oral cancer treatment market. Europe is expected to grow in the global oral cancer treatment market with a healthy CAGR over the forecast period. The growing healthcare expenditure propels the growth of Europe’s oral cancer treatment market. Asia-Pacific is expected to be growing in the global oral cancer treatment market.
The report on the global oral cancer treatment market covers segments such as product type, treatment, and application. On the basis of product type, the sub-markets include squamous cell carcinoma, verrucous carcinoma, minor salivary gland carcinomas, and lymphomas. On the basis of treatment, the sub-markets include surgery, radiation therapy, targeted therapy, chemotherapy, and other treatments. On the basis of application, the sub-markets include hospitals and clinics, research organizations, and academic institutes.
Browse Detailed TOC, Description, and Companies Mentioned in Report @ https://www.infiniumglobalresearch.com/healthcare-medical-devices/global-oral-cancer-treatment-market
The report provides profiles of the companies in the market such as Eli Lilly and Company, Merck & Co., Inc., F. Hoffmann-La-Roche Ltd., Teva Pharmaceutical Industries Ltd., Bristol-Myers Squibb Company, Novartis AG, Qilu Pharmaceutical Co. Ltd., Pfizer Inc., Sanofi S.A., Mylan N.V., and other companies.
Reasons to Buy this Report:
=> Comprehensive analysis of global as well as regional markets of the oral cancer treatment.
=> Complete coverage of all the product type and application segments to analyze the trends, developments, and forecast of market size up to 2025.
=> Comprehensive analysis of the companies operating in this market. The company profile includes analysis of product portfolio, revenue, SWOT analysis and the latest developments of the company.
=> Infinium Global Research- Growth Matrix presents an analysis of the product segments and geographies that market players should focus to invest, consolidate, expand and/or diversify.